The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury
Status:
Active, not recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
The primary objective is to safely determine if the investigators can identify the severity
of Acute Kidney Injury (AKI) early in the course of the disease. Once enrolled the
investigators will draw blood and urine for novel and standard biomarkers. The investigators
are attempting to determine if these biomarkers can forecast the course of AKI (need for
dialysis, death and renal recovery). The investigators seek to determine how well physicians
caring for those with AKI can predict the clinical course compared to these novel biomarkers
of AKI and if there is an association between clinical course and 3 year patient outcomes.